These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18538090)

  • 1. [Preparation of iodine-125 labeled anti-human CD40 monoclonal antibody 5H6 and its binding properties in ovary cancer cell line HO8910 in vitro].
    Luo XF; Zhang B; Ma HB; Tang L; Zhou X; Xu Y; Wu YW; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):590-3. PubMed ID: 18538090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10.
    Huang WS; Cherng SC; Jen TK; Yu MH; Yeh MY
    J Nucl Med Technol; 2000 Sep; 28(3):182-5. PubMed ID: 11001503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
    Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
    J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-rituximab: relationship between immunoreactivity and specific activity.
    Schaffland AO; Buchegger F; Kosinski M; Antonescu C; Paschoud C; Grannavel C; Pellikka R; Delaloye AB
    J Nucl Med; 2004 Oct; 45(10):1784-90. PubMed ID: 15471849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
    Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
    Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on biodistribution and radioimmunoimaging of (131)iodine-labeled monoclonal antibody D-D3 against progastrin-releasing peptide31-98 in tumor-bearing mouse.
    Liu Z; Zhou X; Shi Y; Du S; Yang Y; Tang J; Shen Y
    Cancer Biother Radiopharm; 2011 Apr; 26(2):229-35. PubMed ID: 21510749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
    J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy with ¹³¹I-bevacizumab as a specific molecule for cells with overexpression of the vascular endothelial growth factor.
    Ashrafi SA; Hosseinimehr SJ; Varmira K; Abedi SM
    Cancer Biother Radiopharm; 2012 Sep; 27(7):420-5. PubMed ID: 22690909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and preparation of technetium-99m-labeled D-D₃ monoclonal antibody against pro-gastrin-releasing peptide (₃₁₋₉₈) in mice.
    Hao LJ; Hong ZH; Shi YZ; Liu ZL; Zhou XL
    Chin Med J (Engl); 2013 Apr; 126(7):1333-6. PubMed ID: 23557567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of a novel functional anti-human CD40 monoclonal antibody and identification of its bioactivity].
    Tang L; Zheng L; Qi CJ; Ma HB; Zhou X; Zhuang YM; Luo XF; Xu Y; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Sep; 23(9):841-3. PubMed ID: 17825232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
    Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
    Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
    Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
    J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Labeling of CDTPA-dianhydride-coupled CD45 monoclonal antibody with yttrium-90].
    Fu YB; Li GP; Meng FY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1230-2. PubMed ID: 16939927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and characterization of a mouse anti-human CD40 mutant monoclonal antibody].
    Zheng SD; Ma HB; Gao C; Whang JM; Sun J; Luo XF; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Oct; 25(10):910-3. PubMed ID: 19811740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of ovarian cancer by 198Au-labeled human monoclonal antibody.
    Chaudhuri TR; Zinn KR; Morris JS; McDonald GA; Llorens AS; Chaudhuri TK
    Cancer; 1994 Feb; 73(3 Suppl):878-83. PubMed ID: 8306273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-kit-targeted imaging of gastrointestinal stromal tumor using radiolabeled anti-c-kit monoclonal antibody in a mouse tumor model.
    Sogawa C; Tsuji AB; Sudo H; Sugyo A; Yoshida C; Odaka K; Uehara T; Arano Y; Koizumi M; Saga T
    Nucl Med Biol; 2010 Feb; 37(2):179-87. PubMed ID: 20152717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule.
    Matzku S; Kirchgessner H; Dippold WG; Brüggen J
    Eur J Nucl Med; 1985; 11(6-7):260-4. PubMed ID: 4076233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer.
    Scollard DA; Chan C; Holloway CM; Reilly RM
    Nucl Med Biol; 2011 Jan; 38(1):129-36. PubMed ID: 21220136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
    Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
    Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
    Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
    Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.